ABCB1 and neoplasm: Administration of Cre-mediated CD44v6shRNA nanoparticles prevented tumor growth (Figures 10B–D) and strongly inhibited CD44v6 and MDR1 expressions (Figure 10E) in a dose-dependent manner.